Parsey Merdad 4
4 · ArriVent BioPharma, Inc. · Filed Apr 29, 2025
Insider Transaction Report
Form 4
Parsey Merdad
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-28+28,346→ 28,346 totalExercise: $20.92Exp: 2035-04-27→ Common Stock (28,346 underlying)
Footnotes (1)
- [F1]These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date.